Official Study Title Scoring PErsonalized needs in Clostridium difficile Infections for Fidaxomixin therapY
The SPECIFY study is a non-interventional study aiming to develop a complex score composed by clinical data, genomic data and protein biomarkers to early predict patients with infection by Clostridium difficile at high likelihood to develop organ failure, relapse of the infection or die.
Study Type: Non-Interventional
Study phase: II
Study sites: 12 sites in Greece
Actual enrolment: 153 participants